GABPB1 downregulation inhibits peroxiredoxin-5 (PRDX5) expression to abrogate antioxidative capacities, which finally increases the accumulation of lipid ROS and promotes ferroptosis in HCC cells [85]. Here, PRDX5 is linked to hepatocellular carcinoma.